Pharmaprdeict Attrition Analysis

Success Analysis - Full Report

Therapy % Success Rate
Preclinical-Launch % Success Rate
Phase I-Launch % Success Rate
Phase II-Launch % Success Rate
Phase III-Launch % Success Rate
Pre-registration-Launch % Success Rate
Registration-Launch Failure Rate
Post Launch

Therapy All Drugs Therapy All Drugs Therapy All Drugs Therapy All Drugs Therapy All Drugs Therapy All Drugs Therapy All Drugs

Anorectic/Antiobesity, A8A3 3 10 18 41 32 53 86 76 86 89 86 94 17 3

Antidiabetic, A10B 4 10 27 41 38 53 73 76 90 89 95 94 5 3

Hypolipaemic/Antiatherosclerosis, C10 7 10 34 41 48 53 85 76 95 89 95 94 5 3

Dependence treatment, N9A 8 10 40 41 50 53 60 76 75 89 75 94 33 3

Therapy	% Success Rate Preclinical-Launch		% Success Rate Phase I-Launch		% Success Rate Phase II-Launch		% Success Rate Phase III-Launch		% Success Rate Pre-registration-Launch		% Success Rate Registration-Launch		Failure Rate Post Launch
	Therapy	All Drugs	Therapy	All Drugs	Therapy	All Drugs	Therapy	All Drugs	Therapy	All Drugs	Therapy	All Drugs	Therapy	All Drugs
Anorectic/Antiobesity, A8A3	3	10	18	41	32	53	86	76	86	89	86	94	17	3
Antidiabetic, A10B	4	10	27	41	38	53	73	76	90	89	95	94	5	3
Hypolipaemic/Antiatherosclerosis, C10	7	10	34	41	48	53	85	76	95	89	95	94	5	3
Dependence treatment, N9A	8	10	40	41	50	53	60	76	75	89	75	94	33	3